Detalhe da pesquisa
1.
IFI16-dependent STING signaling is a crucial regulator of anti-HER2 immune response in HER2+ breast cancer.
Proc Natl Acad Sci U S A
; 119(31): e2201376119, 2022 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35878022